Parkside Financial Bank & Trust’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding FLXN
MVP
WA
VVM
O
NHAS
Parkside Financial Bank & Trust's FLXN Position: Q4 2020 in Review
Parkside Financial Bank & Trust sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 280 shares — an estimated $3K sold.
Parkside Financial Bank & Trust first reported a position in FLXN in Q2 2018 and held it in 9 quarters. The position peaked at $6K in Q4 2019. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.
- Parkside Financial Bank & Trust reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 280 Flexion Therapeutics, Inc. shares in Q4 2020, an estimated $3K.
- Parkside Financial Bank & Trust first reported a position in Flexion Therapeutics, Inc. in Q2 2018 and held it in 9 quarters.
- Parkside Financial Bank & Trust's Flexion Therapeutics, Inc. position peaked at $6K in Q4 2019.
- 141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.
Based on Parkside Financial Bank & Trust's 13F filing for Q4 2020, filed 9 Feb 2021.